Drug Interactions in Type 2 Diabetes and Hypertension Patients at RSUD dr. Zainoel Abidin, Banda Aceh
DOI:
https://doi.org/10.35451/34ygtz72Keywords:
Diabetes melitus tipe II, Hipertensi, Interaksi Potensi Obat, Rumah sakit, DMtype 2, Hypertension, Drug interaction potential, HospitalAbstract
DM(DM) is one of the diseases with a high prevalence. Indonesia ranks fifth in the world, contributing 90–95% of all diabetes cases through type 2 DM. This study aimed to identify the characteristics (age, gender, education, occupation), number of medications used, potential drug interactions, severity level of drug interactions, and the association between the number of medications and the potential for drug interactions. This was an observational study with a descriptive quantitative design and retrospective data collection. The sample consisted of 349 patients who met the inclusion criteria: patients with type 2 DM and hypertension, aged ≥18 years, receiving outpatient care at Dr. Zainoel Abidin General Hospital in 2021, and using at least one type 2 DM drug and one antihypertensive drug. The results showed that most patients were aged 56–65 years (36%), male (53.6%), had senior high school education or equivalent (46.4%), and worked as civil servants (25.8%). A total of 56.2% of patients used ≥5 medications. The most commonly used antidiabetic drug was insulin (66.44%), the most common antihypertensive was ARB (37.95%), cardiovascular prevention was dominated by statins (87.24%), and the most frequently used non-antidiabetic and non-antihypertensive drug was PPI (25.19%). A total of 92.8% of patients experienced potential drug interactions, with 1,250 total interactions. The majority were of moderate severity (85.8%) with a pharmacodynamic mechanism (78.8%). The most frequent potential interaction occurred between amlodipine and atorvastatin (3.68%). Chi-square test results showed a statistically significant relationship between the number of medications used and the potential risk of drug interactions.
Downloads
References
1. IDF. IDF Diabetes Atlas 11th Edition [Internet]. UK; 2025. Available from: https://diabetesatlas.org/resources/idf-diabetes-atlas-2025/.
2. BKPK Kemenkes. Survei Kesehatan Indonesia (SKI) 2023 [Internet]. Indonesia; 2023 [cited 2025 Sep 18]. Available from: https://www.badankebijakan.kemkes.go.id/hasil-ski-2023/.
3. Tanara E. Penderita Diabetes Mellitus Capai 154 Ribu di Aceh Tulisan ini telah tayang di AJNN.net dengan judul "Penderita Diabetes Mellitus Capai 154 Ribu di Aceh. Aceh Journal National Network [Internet]. 2025 [cited 2025 Sep 18];
4. Kemenkes RI. Hasil Utama Laporan RISKESDAS 2018 [Internet]. Indonesia; 2018. Available from: https://www.depkes.go.id/resources/download/info-terkini/materi_rakorpop_2018/Hasil Riskesdas 2018.pdf.
5. American Diabetes Association. Introduction and Methodology: Standards of Care in Diabetes. Diabetes Care. 2023;46:S1–S4. doi: 10.2337/dc23-Sint.
6. Nurlaelah I, Mukaddas A, Faustine I. Kajian Interaksi Obat Pada Pengobatan Diabetes Melitus ( DM ) Dengan Hipertensi Di Instalasi Rawat Jalan RSUD UNDATA Periode Maret-Juni Tahun 2014. Jurnal Farmasi Galenika (Galenika Journal of Pharmacy) (e-Journal). 2015;1:35–41. doi: 10.22487/j24428744.2015.v1.i1.4833.
7. Refdanita, Sukmaningsih V. Potensi Interaksi Obat Pasien Diabetes Melitus Tipe-2 dengan Hipertensi di Rumah Sakit “X” Periode 2019. Sainstech Farma (Jurnal Ilmu Kefarmasian) [Internet]. 2021;14:47–53. doi: https://doi.org/10.37277/sfj.v14i1.937.
8. Murwati IS, Murtisiwi L. Identifikasi Potensi Interaksi Obat pada Peresepan Pasien Rawat Jalan Diabetes Melitus Tipe 2 dengan Hipertensi di RSUD dr. Soediran Mangun Sumarso Wonogiri. Jurnal Farmasi (Journal of Pharmacy). 2021;10:38–45. doi: 10.37013/jf.v10i1.119.
9. Afifah H, Dewi IP, Rachmawati E, Holidah D, Norcahyanti I. Drug Interaction Study in Type 2 Diabetes Mellitus with Hypertension Patients at X Hospital, Jember Regency. JURNAL FARMASIMED (JFM). 2024;6:131–141. doi: 10.35451/jfm.v6i2.2051.
10. Siyoto S, Sodik MA. Dasar Metodologi Penelitian. Kediri: Literasi Media Publishing; 2015.
11. Oktaverawati M, Susanti E. Kajian Interaksi Obat pada Peresepan Pasien Diabetes Melitus dengan Komplikasi Hipertensi di Apotek Rawat Jalan JKN RS Dr. Saiful Anwar Malang [Internet] [Diploma thesis]. [Malang]: Akademi Farmasi Putra Indonesia Malang; 2018. Available from: http://repository.poltekkespim.ac.id/id/eprint/534/.
12. WHO. Medication safety in polypharmacy: technical report [Internet]. 2019. Available from: https://iris.who.int/handle/10665/325454.
13. Baxter K. Stockley’s Drug Interactions [Internet]. 9th ed. 2010: Pharmaceutical Press; 2010. Available from: https://www.academia.edu/44684188/Stockleys_Drug_Interactions.
14. Rachmawati S, Pratiwi F, Norcahyanti I. Medication profile and potential drug interactions in diabetes mellitus with hypertension outpatient at RSUD dr. H. Andi Abdurrahman Noor Profil pengobatan dan potensi interaksi obat pada pasien diabetes melitus komplikasi hipertensi di RSUD dr. H. Andi Abdurrahman Noor. Jurnal Ilmiah Farmasi (Scientific Journal of Pharmacy) [Internet]. 2022;Special Edition:60–67.
15. Cahyaningsih I, Wicaksono WA. Penilaian Risiko Interaksi Obat pada Pasien dengan Diabetes Melitus Tipe 2. Indonesian Journal of Clinical Pharmacy. 2020;9:9. doi: 10.15416/ijcp.2020.9.1.9.
16. Soelistijo SA, Lindarto D, Decroli E, Permana H, Sucipto KW, Kusnadi Y, Budiman, Ikhsan R, Sasiarini L, Sanusi H. Pedoman Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 Dewasa di Indonesia 2019. PB PERKENI; 2019.
17. Dipiro JT, Yee GC, Posey LM, Haines ST, Nolin TD, Ellingrod V. Pharmacotherapy: A Pathophysiologic Approach. Eleventh Edition. Hayes PE, editor. New York: McGraw-Hill Education; 2020.
18. American Diabetes Association Professional Practice Committee. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2022. Diabetes Care. 2022;45:S17–S38. doi: 10.2337/dc22-S002.
19. Zeind CS, Carvalho MG. Applied Therapeutics: The Clinical Use of Drugs. 11th ed. Philadelphia: Wolters Kluwer; 2017.
20. Magro L, Arzenton E, Leone R, Stano MG, Vezzaro M, Rudolph A, Castagna I, Moretti U. Identifying and Characterizing Serious Adverse Drug Reactions Associated With Drug-Drug Interactions in a Spontaneous Reporting Database. Front Pharmacol. 2021;11. doi: 10.3389/fphar.2020.622862.
21. Maindoka FS, Mpila D, Citraningtyas G. KAJIAN INTERAKSI OBAT PADA PASIEN GERIATRI RAWAT INAP DI RSUP PROF. DR. R. D. KANDOU MANADO. PHARMACONJurnal Ilmiah Farmasi-UNSRAT. 2017;6. doi: https://doi.org/10.35799/pha.6.2017.16889.
22. Meryta A, Efrilia M, Panca P, Chandra B. GAMBARAN INTERAKSI OBAT HIPOGLIKEMIK ORAL (OHO) DENGAN OBAT LAIN PADA PASIEN DIABETES MELITUS (DM) TIPE II DI APOTEK IMPHI PERIODE OKTOBER 2014 SAMPAI MARET 2015. 2015;1:193–199.
23. Syamsudin. Interaksi Obat: Konsep Dasar dan Klinis. Jakarta: UI Press, Universitas Indonesia; 2011.
24. Astuti W, Rosmiati M. Analisis Interaksi Obat Hiperlipidemia pada Pasien PT. Pertamina di Salah Satu Apotek Kimia Farma di Bandung. Cerdika: Jurnal Ilmiah Indonesia. 2022;2:345–351. doi: 10.36418/cerdika.v2i3.353.
25. Geografi L, Simbolon OM. Potensi Interaksi Antar Obat Pada Pasien Rawat Inap Diabetes Melitus Tipe-2 dengan Komorbiditas Hipertensi. Jurnal Ilmiah Manuntung. 2020;6:129–134.
26. Hidayah K, Kundarto W, Farida Y. Identification of Drug Interaction in Prescribing Drugs for Hypertension Patient with Diabetes Mellitus Identifikasi Potensi Interaksi Obat pada Peresepan Obat Pasien Hipertensi dengan Diabetes Mellitus. 1 Patient Center Care Dalam Penanganan Diabetes Melitus Obese Geriatri Secara Koprehensif. 2018. p. 108–120.
27. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, Lackland DT, LeFevre ML, MacKenzie TD, Ogedegbe O, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311:507–520. doi: 10.1001/jama.2013.284427. Cited: in: : PMID: 24352797.
28. Madania, Rasdianah N, Dalu MC, Pakaya M. Potensi Interaksi Obat Pasien Hipertensi Dan Diabetesmelitus Tipe2 Di Instalasi Rawat Jalan RSUD Toto Kabila. Pharmacoscript [Internet]. 2022;5:56–62.
29. Fitriani A, Padmasari S. Analisis Potensi Interaksi Obat Antidiabetik Pada Pasien Diabetes Melitus Tipe 2 Rawat Inap RS PKU Muhammadiyah Gamping Yogyakarta. Majalah Farmaseutik. 2022;18:37. doi: 10.22146/farmaseutik.v18i1.71905.
30. Parulian LP, Listyanti E, Hati AK, Sunnah I. Analisis Hubungan Polifarmasi Dan Interaksi Obat Pada Pasien Rawat Jalan Yang Mendapat Obat Hipertensi Di Rsp. Dr. Ario Wirawan Periode Januari-Maret 2019. Indonesian Journal of Pharmacy and Natural Product. 2019;2. doi: 10.35473/ijpnp.v2i2.280.
31. Bailie GR, Johnson CA, Mason NA, St. Peter WL. MedFacts Pocket Guide of Drug Interactions [Internet]. 2nd ed. Middleton, Michigan: Bone Care International, Inc. / Nephrology Pharmacy Associates, Inc.; 2004. Available from: http://repo.upertis.ac.id/1644/1/MedFacts%20-%20Pocket%20Guide%20of%20Drug%20Interaction.pdf.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Sahat Saragi
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Copyright in each article is the property of the Author.
